| 201 |
27520522 | Velnacrine in Alzheimer's Disease : An Initial Appraisal of its Clinical Potential. | 1994 Mar |
1 |
| 202 |
8248532 | What have we learned from the THA trials to facilitate testing of new AChE inhibitors. | 1993 |
1 |
| 203 |
8372338 | ["Cerebro-active" drugs]. | 1993 Aug 10 |
1 |
| 204 |
8421706 | Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer disease. | 1993 Jan 15 |
3 |
| 205 |
1538717 | Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase. | 1992 Feb |
10 |
| 206 |
1926583 | [The effect of pH and reversible inhibitors on decarbamylation of acetylcholinesterase]. | 1991 May-Jun |
2 |
| 207 |
1954303 | Inhibition of acetylcholinesterase activity in human brain tissue and erythrocytes by galanthamine, physostigmine and tacrine. | 1991 Aug |
4 |
| 208 |
2655861 | Canadian collaborative study of tetrahydroaminoacridine (THA) and lecithin treatment of Alzheimer's disease: effect on mood. | 1989 Apr |
2 |
| 209 |
2913485 | Tacrine protection of acetylcholinesterase from inactivation by diisopropylfluorophosphate: a circular dichroism study. | 1989 Jan |
14 |
| 210 |
3185960 | Interaction of 9-amino-1,2,3,4-tetrahydroaminoacridine (THA) with human cortical nicotinic and muscarinic receptor binding in vitro. | 1988 Aug 31 |
1 |
| 211 |
1236951 | A hydrophobic binding site in acetylcholinesterase. | 1975 Nov |
2 |